Capital Impact Advisors, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 178 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2020$1,243,000
+2.4%
147,303
+6.2%
0.52%
+22.2%
Q4 2019$1,214,000
-37.7%
138,729
-20.6%
0.43%
-42.5%
Q3 2019$1,949,000
+20.7%
174,641
+37.5%
0.74%
+25.5%
Q2 2019$1,615,000
+3.7%
127,029
+71.9%
0.59%
-14.2%
Q1 2019$1,558,0000.0%73,8760.0%0.69%
+3.6%
Q4 2018$1,558,000
-13.3%
73,876
+88.4%
0.67%
+8.1%
Q3 2018$1,796,000
-12.2%
39,209
+8.0%
0.62%
-18.5%
Q2 2018$2,045,000
+14.6%
36,297
+38.4%
0.76%
+3.0%
Q1 2018$1,785,000
+21.1%
26,229
+75.9%
0.73%
+15.2%
Q4 2017$1,474,000
-17.4%
14,9090.0%0.64%
-20.1%
Q3 2017$1,785,000
+8.2%
14,909
-21.0%
0.80%
+6.1%
Q2 2017$1,650,000
+69.9%
18,874
-27.7%
0.75%
+94.1%
Q1 2017$971,000
+767.0%
26,105
+1649.7%
0.39%
+578.9%
Q3 2015$112,000
-35.6%
1,4920.0%0.06%
-27.8%
Q2 2015$174,000
-50.6%
1,4920.0%0.08%
-50.9%
Q1 2015$352,0001,4920.16%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2018
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders